Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 5
2006 7
2007 6
2008 5
2009 6
2010 7
2011 6
2012 6
2013 16
2014 13
2015 9
2016 10
2017 20
2018 27
2019 29
2020 42
2021 47
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

241 results
Results by year
Filters applied: . Clear all
Page 1
Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension.
Chen Y, Lu W, Yang K, Duan X, Li M, Chen X, Zhang J, Kuang M, Liu S, Wu X, Zou G, Liu C, Hong C, He W, Liao J, Hou C, Zhang Z, Zheng Q, Chen J, Zhang N, Tang H, Vanderpool RR, Desai AA, Rischard F, Black SM, Garcia JGN, Makino A, Yuan JX, Zhong N, Wang J. Chen Y, et al. Among authors: liu c. Br J Pharmacol. 2020 Jun;177(12):2743-2764. doi: 10.1111/bph.15000. Epub 2020 Apr 27. Br J Pharmacol. 2020. PMID: 31976548 Free PMC article.
Pulmonary Vasculature: A Target for COVID-19.
Chen L, Tang R, Chen H, Huang Y, Yi S, Bai Q, Zhu Y, Hong C, Liu C, Zhang N, Wang T. Chen L, et al. Among authors: liu c. Am J Respir Crit Care Med. 2021 Jan 15;203(2):260-261. doi: 10.1164/rccm.202009-3564LE. Am J Respir Crit Care Med. 2021. PMID: 33085902 Free PMC article. No abstract available.
Protein degradation pathways after brain ischemia.
Ge P, Zhang F, Zhao J, Liu C, Sun L, Hu B. Ge P, et al. Among authors: liu c. Curr Drug Targets. 2012 Feb;13(2):159-65. doi: 10.2174/138945012799201694. Curr Drug Targets. 2012. PMID: 22204315 Review.
241 results